Hasti Aria Shimi Company began its operations in 2010 with the aim of manufacturing Active Pharmaceutical Ingredients (APIs) and finished pharmaceutical products. By leveraging up-to-date knowledge, specialized professionals, and infrastructure compliant with international standards, the company has grown into one of Iran’s capable pharmaceutical manufacturers.

Based in the Eshtehard Industrial Zone, this knowledge-based company has successfully obtained GMP certification. Through the exclusive domestic production of mesalazine API and other pharmaceutical products, Hasti Aria Shimi has played an important role in reducing dependence on imported APIs and strengthening self-sufficiency within Iran’s pharmaceutical industry.

Expanding its product portfolio and developing international export markets under the Hita Pharma brand are also among the company’s key strategic priorities.

The participation of companies with this level of expertise, capability, and investment in the pharmaceutical industry reflects the growing confidence of industry stakeholders in Pharmex as the country’s leading specialized platform for the pharmaceutical value chain.

The Pharmex Secretariat invites all API manufacturers, pharmaceutical companies, equipment suppliers, packaging industries, and other stakeholders across the pharmaceutical ecosystem to actively participate in Pharmex Middle East 2026 and take advantage of the event’s exceptional opportunities for networking, industrial collaboration, investment, and international engagement.